Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunfeng Qu

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 1, 2019
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030Rongshou Zheng, Chunfeng Qu, Siwei Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2014
HBV preS2 transactivates FOXP3 expression in malignant hepatocytesXiaoning Zhang, Lifen Gao, Xiaohong Liang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 8, 2018
IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infectionMengya Zang, Yuan Li, Huan He, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 24, 2014
Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant womenLing-Ling Lu, Bing-Xiang Chen, Jiandong Wang, et al.
American Journal of Cancer Research|June 1, 2017
CCR6<sup>+</sup> B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesisHuan He, Jianxiong Wu, Mengya Zang, et al.
Journal of the National Cancer Center|October 20, 2025
Score-based prediction model for female hepatocellular carcinoma surveillance in asymptotic HBsAg carriers: a multicenter cohort study in ChinaMengdi Cao, Maomao Cao, Changfa Xia, et al.
Human Molecular Genetics|December 6, 2012
Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinomaTongwen Zhang, Jianqiang Cai, Jiang Chang, et al.
Signal Transduction and Targeted Therapy|December 20, 2021
Correction: AHR mediates the Aflatoxin B1 toxicity associated with hepatocellular carcinomaQing Zhu, Yarui Ma, Junbo Liang, et al.
Signal Transduction and Targeted Therapy|August 10, 2021
AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinomaQing Zhu, Yarui Ma, Junbo Liang, et al.
Cancer Letters|March 23, 2022
Long term outcome of prevention of liver cancer by hepatitis B vaccine: Results from an RCT with 37 yearsMaomao Cao, Jian Fan, Lingling Lu, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 1, 2019
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030Rongshou Zheng, Chunfeng Qu, Siwei Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2014
HBV preS2 transactivates FOXP3 expression in malignant hepatocytesXiaoning Zhang, Lifen Gao, Xiaohong Liang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 8, 2018
IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infectionMengya Zang, Yuan Li, Huan He, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 24, 2014
Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant womenLing-Ling Lu, Bing-Xiang Chen, Jiandong Wang, et al.
American Journal of Cancer Research|June 1, 2017
CCR6<sup>+</sup> B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesisHuan He, Jianxiong Wu, Mengya Zang, et al.
Journal of the National Cancer Center|October 20, 2025
Score-based prediction model for female hepatocellular carcinoma surveillance in asymptotic HBsAg carriers: a multicenter cohort study in ChinaMengdi Cao, Maomao Cao, Changfa Xia, et al.
Human Molecular Genetics|December 6, 2012
Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinomaTongwen Zhang, Jianqiang Cai, Jiang Chang, et al.
Signal Transduction and Targeted Therapy|December 20, 2021
Correction: AHR mediates the Aflatoxin B1 toxicity associated with hepatocellular carcinomaQing Zhu, Yarui Ma, Junbo Liang, et al.
Signal Transduction and Targeted Therapy|August 10, 2021
AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinomaQing Zhu, Yarui Ma, Junbo Liang, et al.
Cancer Letters|March 23, 2022
Long term outcome of prevention of liver cancer by hepatitis B vaccine: Results from an RCT with 37 yearsMaomao Cao, Jian Fan, Lingling Lu, et al.
Pageof 8